REG - Inspecs Group PLC - Result of AGM

InspecsAnnouncement

19/07/2021 11:45

RNS Number : 6859F
  
Inspecs Group PLC
  
19 July 2021
  
 

19 July 2021
Inspecs Group plc
("Inspecs" the "Company" or "the Group")
Result of AGM
 
Inspecs Group plc, a leading designer, manufacturer and distributor of eyewear frames, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
 



Resolution


For


Against


Withheld


Total votes cast




Number of
votes


%


Number of votes


%


Number of votes








1. 


Ordinary resolution to receive and adopt the Company's annual accounts and reports


77,124,504


83.88%


14,820,434


16.12%


1,960,678


93,905,616




2.


Ordinary resolution to re-elect Lord MacLaurin as a director of the Company.


78,159,511


97.60%


1,921,749


2.40%


13,824,356


93,905,616




3.


Ordinary resolution to re-elect Robin Totterman as a director of the Company.


93,905,616


100.00%


0


0.00%


0


93,905,616




4.
 
 


Ordinary resolution to re-elect Christopher Kay as a director of the Company.


93,905,616


100.00%


0


0.00%


0


93,905,616




5.
 
 


Ordinary resolution to re-elect Christopher Hancock as a director of the Company.


71,500,121


80.91%


16,867,834


19.09%


5,537,661


93,905,616




6.
 
 


Ordinary resolution to re-elect Richard Peck as a director of the Company.


72,227,206


81.73%


16,140,749


18.27%


5,537,661


93,905,616




7.
 
 


Ordinary resolution to re-elect Angela Farrugia as a director of the Company.


87,939,607


97.36%


2,389,026


2.64%


3,576,983


93,905,616




8.


Ordinary resolution to re-appoint Ernst & Young LLP as the Company's auditors to hold office from the conclusion of this meeting until the conclusion of the next meeting, in accordance with normal practice.


93,178,531


99.23%


727,085


0.77%


0


93,905,616




9.


Ordinary resolution to authorise the directors to determine the remuneration of the auditors


93,178,531


99.23%


727,085


0.77%


0


93,905,616




10.
 
 


Ordinary resolution to enable the Company and each of its subsidiaries to make political donations and expenditure. 


93,177,431


99.22%


728,185


0.78%


0


93,905,616




11.


Ordinary resolution to authorise the directors to allot ordinary shares in the Company up to a maximum nominal amount of £337,636.32 and up to a further
maximum nominal amount of £337,636.32 where the allotment is in connection with an offer by way of a rights issue.


93,178,531


99.23%


727,085


0.77%


0


93,905,616




12.


Special resolution to enable the directors to allot, grant options over or otherwise dispose of equity securities for cash or sell treasury shares for cash up to a maximum aggregate nominal amount of £50,645.44 as if pre-emption rights did not apply to such allotment.


91,904,493


97.87%


2,001,123


2.13%


0


93,905,616




13.


Special Resolution to further disapply pre-emption rights in relation to acquisitions or other capital investments.


91,904,493


97.87%


2,001,123


2.13%


0


93,905,616




14.


Special resolution to authorise the Company to make market purchases of up to 10,129,089 ordinary shares (which represents approximately 10 per cent of the Company's ordinary shares (excluding treasury shares) in issue on 23 June 2021).


93,178,531


99.23%


727,085


0.77%


0


93,905,616



 
 
For further information please contact:
 



Inspecs Group plc
Robin Totterman (CEO)
Chris Kay (CFO)
 


via FTI Consulting
Tel: +44 (0) 20 3727 1000




Peel Hunt (Nominated Adviser and Broker)
Adrian Trimmings
Andrew Clark 
 
 


Tel: +44 (0) 20 7418 8900




FTI Consulting (Financial PR)
Alex Beagley
Fern Duncan 
Alice Newlyn 
 
 


Tel: +44 (0) 20 3727 1000



About Inspecs Group plc
INSPECS is a Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses. The Group produces a broad range of frames and lenses, covering optical, sunglasses and safety, which are either "Branded" (either under licence or under the Group's own proprietary brands), or "OEM" (including private label on behalf of retail customers and un-branded).
In December 2020, INSPECS acquired Eschenbach Optik, a leading, global, eyewear supplier headquartered in Nuremberg, Germany, which includes the American company Tura. The acquisition extended the Group's presence internationally in key global markets. This followed the acquisition of lens maker Norville in July 2020, whereby INSPECS combined two heritage brands in British optical, Savile Row frame maker, and Norville lens maker, further enhancing its vertically integrated business model. As one of only a few companies that can offer this one-stop-shop solution to global retail chains, INSPECS is well positioned to continue to take market share in the globally expanding eyewear market.
INSPECS customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 70,000 points of sale.
INSPECS has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy. With the acquisition of Eschenbach Optik, the Group's international reach further extends across Europe and the American markets.
The Group's growth strategy going forward is to: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group's internal capabilities); and (iii) extend the Group's manufacturing capacity.
 
More information is available at: https://inspecs.com   

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
RAGUKSRRARUBAAR